Connection

Jean Bousquet to Omalizumab

Back to Details
This is a "connection" page, showing publications Jean Bousquet has written about Omalizumab.
Jean Bousquet
Connection Strength
0.805
Omalizumab
  1. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma. Respir Med. 2019 04; 150:51-62.
    View in: PubMed
    Score: 0.642
  2. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1418-1429.
    View in: PubMed
    Score: 0.162
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.